NO20023783D0 - Partnere av PTB 1-domene av FE65, fremstilling og anvendelse derav - Google Patents
Partnere av PTB 1-domene av FE65, fremstilling og anvendelse deravInfo
- Publication number
- NO20023783D0 NO20023783D0 NO20023783A NO20023783A NO20023783D0 NO 20023783 D0 NO20023783 D0 NO 20023783D0 NO 20023783 A NO20023783 A NO 20023783A NO 20023783 A NO20023783 A NO 20023783A NO 20023783 D0 NO20023783 D0 NO 20023783D0
- Authority
- NO
- Norway
- Prior art keywords
- partners
- ptb
- domain
- preparation
- present
- Prior art date
Links
- 102100036439 Amyloid beta precursor protein binding family B member 1 Human genes 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000012202 endocytosis Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000010189 intracellular transport Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Soft Magnetic Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001628A FR2804962B1 (fr) | 2000-02-10 | 2000-02-10 | Partenaires du domaine ptb1 de fe65, preparation et utilisations |
| US19850000P | 2000-04-18 | 2000-04-18 | |
| PCT/FR2001/000361 WO2001059104A1 (fr) | 2000-02-10 | 2001-02-07 | Partenaires du domaine ptb1 de fe65, preparation et utilisations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20023783D0 true NO20023783D0 (no) | 2002-08-09 |
| NO20023783L NO20023783L (no) | 2002-09-09 |
| NO330798B1 NO330798B1 (no) | 2011-07-18 |
Family
ID=26212162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023783A NO330798B1 (no) | 2000-02-10 | 2002-08-09 | Polypeptid, nukleinsyre, vektor, virus, antistoff, farmasoytisk preparat samt fremgangsmate for fremstilling og screening |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6696273B2 (no) |
| EP (1) | EP1257642B1 (no) |
| KR (1) | KR100802687B1 (no) |
| AT (1) | ATE415476T1 (no) |
| AU (2) | AU3562501A (no) |
| BR (1) | BR0108247A (no) |
| CA (1) | CA2399939A1 (no) |
| CY (1) | CY1108758T1 (no) |
| DE (1) | DE60136688D1 (no) |
| DK (1) | DK1257642T3 (no) |
| ES (1) | ES2315273T3 (no) |
| IL (1) | IL151147A0 (no) |
| MX (1) | MXPA02007620A (no) |
| NO (1) | NO330798B1 (no) |
| NZ (1) | NZ520697A (no) |
| PT (1) | PT1257642E (no) |
| WO (1) | WO2001059104A1 (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10146737A1 (de) * | 2001-09-22 | 2003-04-10 | Aventis Pharma Gmbh | Coniosulfide und deren Derivate, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5389526A (en) * | 1989-11-02 | 1995-02-14 | Slade; Martin B. | Plasmid vectors for cellular slime moulds of the genus dictyostelium |
| US5928882A (en) * | 1997-10-24 | 1999-07-27 | The Rockefeller University | Treatment and prevention of neurodegenerative diseases using modulators of Fe65 |
| AU1536399A (en) * | 1997-11-26 | 1999-06-15 | Genetics Institute Inc. | Secreted proteins and polynucleotides encoding them |
| US6214582B1 (en) * | 1998-11-16 | 2001-04-10 | The Research Foundation Of State University Of Ny | Y2H35 a strong IKK binding protein |
-
2001
- 2001-02-07 AT AT01907727T patent/ATE415476T1/de active
- 2001-02-07 WO PCT/FR2001/000361 patent/WO2001059104A1/fr active IP Right Grant
- 2001-02-07 IL IL15114701A patent/IL151147A0/xx unknown
- 2001-02-07 PT PT01907727T patent/PT1257642E/pt unknown
- 2001-02-07 MX MXPA02007620A patent/MXPA02007620A/es active IP Right Grant
- 2001-02-07 AU AU3562501A patent/AU3562501A/xx active Pending
- 2001-02-07 ES ES01907727T patent/ES2315273T3/es not_active Expired - Lifetime
- 2001-02-07 BR BR0108247-7A patent/BR0108247A/pt not_active IP Right Cessation
- 2001-02-07 NZ NZ520697A patent/NZ520697A/en not_active IP Right Cessation
- 2001-02-07 DE DE60136688T patent/DE60136688D1/de not_active Expired - Lifetime
- 2001-02-07 CA CA002399939A patent/CA2399939A1/fr not_active Abandoned
- 2001-02-07 KR KR1020027010351A patent/KR100802687B1/ko not_active IP Right Cessation
- 2001-02-07 DK DK01907727T patent/DK1257642T3/da active
- 2001-02-07 EP EP01907727A patent/EP1257642B1/fr not_active Expired - Lifetime
- 2001-02-07 AU AU2001235625A patent/AU2001235625B2/en not_active Ceased
- 2001-02-09 US US09/780,996 patent/US6696273B2/en not_active Expired - Fee Related
-
2002
- 2002-08-09 NO NO20023783A patent/NO330798B1/no not_active IP Right Cessation
-
2003
- 2003-12-03 US US10/726,721 patent/US6942982B2/en not_active Expired - Fee Related
-
2009
- 2009-02-05 CY CY20091100140T patent/CY1108758T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL151147A0 (en) | 2003-04-10 |
| EP1257642B1 (fr) | 2008-11-26 |
| DE60136688D1 (de) | 2009-01-08 |
| BR0108247A (pt) | 2002-11-05 |
| AU2001235625B2 (en) | 2007-01-11 |
| CY1108758T1 (el) | 2014-04-09 |
| ES2315273T3 (es) | 2009-04-01 |
| NO20023783L (no) | 2002-09-09 |
| NO330798B1 (no) | 2011-07-18 |
| MXPA02007620A (es) | 2002-12-13 |
| PT1257642E (pt) | 2009-01-30 |
| EP1257642A1 (fr) | 2002-11-20 |
| US6696273B2 (en) | 2004-02-24 |
| NZ520697A (en) | 2005-11-25 |
| WO2001059104A1 (fr) | 2001-08-16 |
| KR20020079844A (ko) | 2002-10-19 |
| US6942982B2 (en) | 2005-09-13 |
| US20040166109A1 (en) | 2004-08-26 |
| US20020061553A1 (en) | 2002-05-23 |
| DK1257642T3 (da) | 2009-03-30 |
| ATE415476T1 (de) | 2008-12-15 |
| CA2399939A1 (fr) | 2001-08-16 |
| KR100802687B1 (ko) | 2008-02-12 |
| AU3562501A (en) | 2001-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0208338A (pt) | Derivados de piridina | |
| BR9812634A (pt) | April - uma proteìna com efeitos de crescimento | |
| ATE288893T1 (de) | Polymorphe form von atorvastatin-calcium | |
| MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
| NO330934B1 (no) | Flytende farmasoytisk preparat samt anvendelse og fremstilling derav. | |
| DOP2001000297A (es) | Nuevas imidazotriazinonas sustituidas | |
| EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
| DK1273299T3 (da) | Minoxidilinindeholdende praparater | |
| WO2002011666A3 (en) | Derivatives of branched-chain lipophilic molecules and uses thereof | |
| WO2004039326A3 (en) | Propofol with cysteine | |
| NO20023783D0 (no) | Partnere av PTB 1-domene av FE65, fremstilling og anvendelse derav | |
| IL193310A0 (en) | Antibody directed against a polypeptide that interacts with parkin and pharmaceutical compositions comprising the same | |
| WO2002032445A3 (de) | Hemmung der interaktion zwischen oxidierte proteine und cd36 oder dessen wirkmechanismus | |
| DE69905489D1 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
| ATE238791T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum | |
| ATE247649T1 (de) | Disubstituierte biphenyloxazoline | |
| DE60225530D1 (de) | Phosphorylierte glyoxalase i und deren verwendung | |
| DE69602208T2 (de) | Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine | |
| BR0211762A (pt) | Certos policetìdeos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores | |
| DE60226126D1 (de) | Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen | |
| EA200200321A1 (ru) | Апоптин-ассоциированный белок | |
| BR0306869A (pt) | Composição farmacêutica orodispersìvel de piribedila | |
| DE60203726D1 (de) | Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden | |
| BG100456A (en) | Ranitidine and calcium carbonate pharmaceutical product | |
| ATE382342T1 (de) | Pomolsäure zur behandlung von mehrfachresistenten tumoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |